Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07512323Phase 2Not Yet Recruiting

Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency

Role: lead

NCT07135245Phase 2Not Yet Recruiting

Improved Treatment and Monitoring of Alzheimer's Disease

Role: lead

NCT06815692Not Yet Recruiting

Interdisciplinary Interventions After mTBI

Role: lead

NCT06161129Not ApplicableNot Yet Recruiting

Filter Lenses for the Prevention of Migraine Attacks

Role: lead

All 4 trials loaded